Sunday, October 26, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Citigroup Trims Target on Tradeweb Despite Record Trading Activity

Andreas Sommer by Andreas Sommer
September 9, 2025
in Analysis, Banking & Insurance, Trading & Momentum
0
Tradeweb Markets Stock
0
SHARES
124
VIEWS
Share on FacebookShare on Twitter

While Tradeweb Markets Inc. continues to post impressive trading volumes, Citigroup has opted to tighten its expectations. The financial giant has maintained its ‘Buy’ recommendation but made a significant downward revision to its price target, sending a mixed message to investors.

The adjustment, announced yesterday, sees the price objective lowered to $150 from $170, an 11.76% reduction. This decision by Citigroup’s analysts follows the release of Tradeweb’s operational metrics for August, which highlighted robust activity across its electronic trading platforms.

Strong Volumes Underscore Operational Strength

Tradeweb’s latest metrics reveal a business performing well. The company reported a total trading volume of $54.1 trillion for August. This equated to an average daily volume (ADV) of $2.5 trillion, marking a solid 11.3% increase compared to the same period last year.

Growth was particularly vigorous in several key product areas:
* Repurchase agreements (Repo): ADV surged 16.6% to $750.4 billion
* European government bonds: ADV climbed 20.4%, reaching $44.3 billion
* Interest rate derivatives: Total ADV expanded by 20.8% to $878.5 billion
* European credit products: ADV rose 23.8% to $1.8 billion

Should investors sell immediately? Or is it worth buying Tradeweb Markets?

The sole underperformer was U.S. government debt, which saw a 3.9% decline in activity. This dip was attributed primarily to softer volume from both institutional and retail client segments.

Investor Focus Shifts to Upcoming Conference

Market attention now turns to the Barclays Global Financial Services Conference, where Tradeweb is scheduled to present today. These events often provide management with a platform to offer further context on recent performance and detail their strategic roadmap for the future.

The critical question for the market is whether this presentation can counterbalance the cautious tone from Citigroup. The overall analyst consensus for Tradeweb remains favorable, carrying a “Moderate Buy” rating. The average price target among analysts sits at $151.93.

The next major catalyst for the stock will arrive on October 30, when the company is slated to report its full financial results for the third quarter of 2025. Currently, Tradeweb shares are trading near $119, a level that remains substantially below most analyst projections despite the recent target cut.

Ad

Tradeweb Markets Stock: Buy or Sell?! New Tradeweb Markets Analysis from October 26 delivers the answer:

The latest Tradeweb Markets figures speak for themselves: Urgent action needed for Tradeweb Markets investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 26.

Tradeweb Markets: Buy or sell? Read more here...

Tags: Tradeweb Markets
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

MP Materials Stock
Analysis

MP Materials Shares Face Sharp Decline Amid Valuation Concerns

October 26, 2025
Arcus Biosciences Stock
Analysis

Biotech Analyst Battle: Arcus Biosciences Faces Conflicting Outlooks

October 26, 2025
Xeris Pharmaceuticals Stock
Analysis

Xeris Pharmaceuticals Shares Extend Rally to Fresh Peak

October 26, 2025
Next Post
AbbVie Stock

Three Strategic Moves Position AbbVie for Future Growth

Markel Stock

Strategic Refinement Drives Markel's Path Forward

Ecopetrol Stock

Strategic Shift for Ecopetrol Following Venezuela Sanctions

Recommended

Akero Therapeutics Stock

Analyst Confidence Soars for Akero Therapeutics Following Key Presentations

2 months ago
Applovin Stock

Applovin’s Strategic Shift: Can New Ad Platform Drive Growth Beyond Gaming?

3 weeks ago
MA stock news

Jefferies Analyst Downgrades Solo Brands Revises Price Target

2 years ago
BAE Systems Stock

Defense Stocks Surge as Geopolitical Tensions Intensify

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Nike NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

HNI Shares Face Pivotal Week with Earnings and Acquisition Finale

Hims & Hers Stock Plunge: A Perfect Storm of Insider Selling and Leadership Shifts

Pfizer Secures Key Regulatory Wins Amid Ongoing Legal Challenges

Porsche’s Corporate Overhaul Faces Billion-Euro Hurdles

Harmony Biosciences Shares Surge on Blockbuster Drug Performance

Two EV Trailblazers: Assessing Rivian and Lucid’s Divergent Paths

Trending

MP Materials Stock
Analysis

MP Materials Shares Face Sharp Decline Amid Valuation Concerns

by Robert Sasse
October 26, 2025
0

Shares of MP Materials experienced a significant downturn last week, shedding 12.1% of their value in just...

Arcus Biosciences Stock

Biotech Analyst Battle: Arcus Biosciences Faces Conflicting Outlooks

October 26, 2025
Xeris Pharmaceuticals Stock

Xeris Pharmaceuticals Shares Extend Rally to Fresh Peak

October 26, 2025
HNI Stock

HNI Shares Face Pivotal Week with Earnings and Acquisition Finale

October 26, 2025
Hims & Hers Health Registered (A) Stock

Hims & Hers Stock Plunge: A Perfect Storm of Insider Selling and Leadership Shifts

October 26, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • MP Materials Shares Face Sharp Decline Amid Valuation Concerns
  • Biotech Analyst Battle: Arcus Biosciences Faces Conflicting Outlooks
  • Xeris Pharmaceuticals Shares Extend Rally to Fresh Peak

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com